DHR Chart

1 Month

	Date	Diff
	2025-04-01	-2.25 %
Danaher Corporation (DHR) stock fell by 2.25% due to a combination of high trading volume and potential market fluctuations affecting the biotech sector, which often experiences volatility stemming from drug development and regulatory challenges.
	2025-03-27	-0.14 %
Danaher Corporation (DHR) stock declined by 0.14%, reaching $212.28 due to a combination of low trading volume compared to its average and the overall volatility affecting biotech stocks.
	2025-03-24	+0.68 %
Danaher Corporation (NYSE:DHR) stock rose by 0.68% as it benefits from strong financial performance, strategic acquisitions, and growth in the clinical diagnostics market driven by rising demand for lab automation and AI-powered diagnostics tools. The increase in DHR stock is attributed to its strong free cash flow generation, successful mergers and acquisitions, and a favorable market outlook for its biotechnology and life sciences sectors. Danaher Corporation (DHR) stock rose 0.68% after Goldman Sachs upgraded its rating from neutral to buy, setting a price target of $260.00, contributing to positive momentum from other bullish analyst ratings.
	2025-03-21	+0.53 %
Danaher Corporation (DHR) stock rose 0.53% following a general trend of institutional investors adjusting their positions, with both new stakes being established and others reducing holdings, alongside positive analysts' ratings and expected earnings performance. Danaher Corporation (DHR) saw a 0.53% increase in its stock price, rising to $211.24, as part of a broader interest in prominent biotech stocks as they exhibit high trading volumes and growth potential amidst innovations in healthcare. The rise in Danaher Corporation's stock can be attributed to its strong performance in the biotechnology sector, where it offers a wide range of products and services that advance the development and manufacturing of therapeutics, which may attract investor interest and confidence in the company's future growth.
	2025-03-19	-1.18 %
Danaher Corporation's (DHR) stock dropped by 1.18% due to overall volatility in the biotech sector, influenced by significant trading activity in other biotech stocks, which can shift investor focus and sentiment.
	2025-03-17	+0.88 %
Danaher Corporation's (DHR) stock rose by 0.88% as it received a consensus recommendation of "Moderate Buy" from analysts, with multiple price target upgrades, positive earnings reports, and an upcoming dividend increase contributing to investor confidence.
	2025-03-14	+3.26 %
Danaher Corporation (DHR) stock rose 3.26% recently as part of a notable increase in interest in biotech stocks, driven by high trading volumes and market momentum, particularly related to advancements in biotechnology and healthcare innovations.
	2025-03-13	-0.42 %
Danaher Corporation (DHR) stock decreased by 0.42% due to overall market dynamics affecting biotech stocks, despite being highlighted as one of the biotech stocks to watch. The decline in Danaher Corporation's stock could be attributed to broader market trends affecting biotech investments, including high risk and regulatory challenges prevalent in the industry, as also indicated by the movements of other companies like AbbVie and Thermo Fisher Scientific experiencing stock downticks at the same time.
	2025-03-12	-0.32 %
Danaher Corporation's stock (DHR) decreased by 0.32%, closing at $207.62, amid broader volatility in biotech stocks likely influenced by uncertainties in research, development, and regulatory environments.
	2025-03-11	+0.19 %
Danaher Corporation's (DHR) stock saw a slight increase of 0.19% amid a focus on biotechnology stocks, which generally experience high volatility and trading volume due to ongoing innovations and developments in the sector. The rise in Danaher's stock can be attributed to its strong position within the biotech industry, as it produces essential products and services that support the development and manufacturing of therapeutics and other medical advancements, thus attracting investor interest.
	2025-03-10	-3.23 %
Danaher Corporation (DHR) stock declined by 3.23% to $212.35 amid overall high volatility in the biotech sector, influenced by fluctuating trader sentiment, regulatory risks, and market movements impacting related stocks.
	2025-03-07	-1.28 %
Danaher Corporation's stock (DHR) is down by 1.28% amid increased volatility in the biotech sector, influenced by market conditions and trading behaviors impacting shares of biotechnology firms like Moderna and AbbVie.
	2025-03-06	+2.02 %
Danaher Corporation (DHR) stock increased by 2.02% as it is among the biotech stocks gaining attention due to high dollar trading volumes in the sector, suggesting increased investor interest likely driven by positive market conditions or company-specific developments.
	2025-02-25	-0.35 %
Danaher Corporation's (DHR) stock declined by 0.35% after Zacks Research reduced its Q1 2025 earnings per share estimate from $2.00 to $1.62, contributing to investor concerns and market reactions.
	2025-02-18	-0.86 %
Danaher Corporation (DHR) stock declined by 0.86% due to general market volatility typically affecting biotech stocks, which can experience price fluctuations based on regulatory approvals and clinical trial results.
	2025-02-14	+1.33 %
Danaher Corporation (DHR) stock rose 1.33% mainly due to favorable analyst ratings and recent quarterly earnings that met expectations, reflecting robust institutional investor interest despite a minor insider sale by Representative Julie Johnson.
	2025-02-13	+0.7 %
Danaher Corporation's stock (DHR) rose by 0.7% due to increased institutional investment and positive earnings reports, despite some analysts adjusting their price targets downwards. Danaher Corporation's stock rose by 0.7% as it maintained significant trading volume amid investor interest in biotech stocks, which are influenced by developments in the research and production of biological products, suggesting positive market sentiment toward Danaher's role in innovative healthcare solutions.
	2025-02-12	+0.28 %
The Danaher Corporation (DHR) stock recently rose by 0.28% due to its strong financial performance, diversified portfolio, and positive analyst ratings, contributing to investor confidence in its long-term growth prospects within the manufacturing sector.
	2025-02-07	-1.55 %
Danaher Corporation (DHR) stock fell by 1.55% to $212.94 amid a broader focus on biotech stocks, reflecting market volatility and potential investor concerns about its performance compared to its historical highs and recent trading averages.
	2025-02-05	-1.34 %
Danaher Corporation's stock (DHR) declined by 1.34% as analysts issued mixed ratings and lowered price targets, which may have contributed to negative investor sentiment.
	2025-02-04	+0.35 %
Danaher Corporation's stock (DHR) rose by 0.35% amid mixed analyst projections for its upcoming earnings, with some analysts lowering their estimates while others maintained or increased their target prices, reflecting investor confidence in the company's long-term prospects despite short-term adjustments.
	2025-02-03	-3.81 %
Danaher Corporation (DHR) stock dropped by 3.81% after Leerink Partners reduced their Q1 2025 earnings estimate from $2.02 to $1.63 per share, indicating concerns about the company's future financial performance.
	2025-01-31	-0.15 %
Danaher Corporation (DHR) stock declined by 0.15% after Citigroup lowered its price target from $285 to $265, which triggered a pre-trading gap down in share price from its previous close of $247.84 to an opening price of $235.02. Danaher Corporation's stock (NYSE:DHR) fell by 0.15% following a price target reduction by Jefferies Financial Group from $285.00 to $260.00, amidst other analysts lowering their price targets for the company. Danaher Corporation (DHR) shares recently fell due to disappointing earnings results that missed analyst expectations, leading to downgraded revenue and earnings forecasts from analysts, which has negatively impacted investor sentiment.
	2025-01-30	-0.29 %
Danaher Corporation's (DHR) stock fell -0.29% after Jefferies Financial Group downgraded their price target from $285.00 to $260.00, contributing to a drop to a new 52-week low.
	2025-01-29	-9.73 %
Danaher Corporation (DHR) stock experienced a significant decline of -9.73%, attributed to recent market reactions and potential investor concerns following broader economic updates and investor sentiment shifts. Danaher Corporation (DHR) stock fell by 9.73% recently, potentially due to market reactions to broader economic trends and investor concerns surrounding upcoming government budget implications that might affect corporate profitability or investor sentiment.
	2025-01-27	+1.95 %
Danaher Corporation's stock (DHR) rose by 1.95% ahead of its upcoming earnings report, where analysts expect strong earnings and revenue figures, along with positive shifts in target price ratings from various financial institutions indicating confidence in the company's future performance.
	2025-01-24	+0.06 %
Danaher Corporation (DHR) reported a small increase of 0.06% in its stock value, attributed to strong quarterly earnings that surpassed analysts' expectations, as well as ongoing institutional interest in the company. Danaher Corporation's (DHR) stock increased by 0.06% following an upward revision of its FY2024 earnings estimates by Leerink Partners, which now anticipates earnings per share of $7.52, slightly above the previous estimate, reflecting investor confidence and positive analyst sentiment.
	2025-01-22	+0.03 %
Danaher Corporation's (DHR) stock saw a minor increase of 0.03% despite Raymond James lowering its price target from $300 to $275 while maintaining an "outperform" rating, which likely reflects investor confidence bolstered by positive earnings results and continued support from various analysts. Danaher Corporation (DHR) stock increased by 0.03% amidst a focus on biotech stocks with high trading volumes. The rise in Danaher's stock is likely due to its significant engagement in biotechnology products and services, which aligns with current market interest in the biotech sector. Danaher Corporation (DHR) stock rose by 0.03% due to continued interest from institutional investors and positive quarterly earnings results that exceeded analyst expectations, alongside the announcement of a dividend payout.
	2025-01-21	+2.41 %
Danaher Corporation's stock (NYSE:DHR) rose by 2.41% due to strong earnings performance that exceeded analyst expectations, with revenue growth and positive ratings from several brokerages indicating a favorable outlook. The article discusses Danaher Corporation's (DHR) recent stock performance, which rose by 2.41%, alongside changes in institutional investments and analyst ratings that reflect a generally positive outlook for the company. The increase in Danaher Corporation's stock price can be attributed to strong quarterly earnings that exceeded expectations, positive analyst ratings, and a growing consensus that signals continued investor interest and confidence in the company's future performance.
	2025-01-16	+1.65 %
Danaher Corporation (DHR) stock rose by 1.65% following an earnings report that exceeded analysts' expectations despite a reduction in future earnings estimates by William Blair. The stock's increase may be attributed to strong quarterly earnings and revenue results that outperformed Wall Street's projections, indicating resilience in the company's financial performance.
	2025-01-15	+0.15 %
Danaher Corporation (DHR) stock increased by 0.15% following significant institutional investment, notably a 265.5% boost in shares by Capital Investment Advisors LLC during the fourth quarter, indicating strong confidence in the company's performance and financial stability.
	2025-01-14	-0.94 %
Danaher Corporation (DHR) stock decreased by 0.94%, potentially due to Aprio Wealth Management LLC reducing its holdings by 22%, along with mixed analyst ratings and target price adjustments from various investment firms.
	2025-01-13	+2.05 %
Danaher Corporation's (DHR) stock rose 2.05% due to positive analyst ratings, including an upgraded price target and improved quarterly earnings that exceeded expectations, indicating a strong financial performance.
	2025-01-10	-1.27 %
Danaher Corporation's (DHR) stock fell by 1.27% amid a flurry of institutional investment activity, with the company's recent quarterly earnings outperforming expectations but its stock facing downward pressure likely due to shifts in market sentiment and price target adjustments by analysts.
	2025-01-06	+1.43 %
Danaher Corporation's (DHR) stock rose by 1.43% due to positive earnings performance surpassing analyst expectations, a robust revenue growth, and optimistic ratings from equity research analysts. Danaher Corporation's stock (DHR) rose 1.43% following positive quarterly earnings results that exceeded analysts’ expectations and a series of institutional investments that indicate growing confidence in the company's financial stability and growth potential.
	2024-12-24	+0.69 %
Danaher Corporation (DHR) shares rose by 0.69% following positive coverage and target price adjustments from several analysts, including Scotiabank's new sector perform rating with a $265 target, reflecting overall investor confidence based on strong earnings results and forecasts.
	2024-12-16	-0.3 %
Danaher Corporation's stock declined by 0.3% after Leerink Partners reduced their Q1 2025 earnings per share estimates for the company, projecting a less optimistic outlook compared to previous estimates. Danaher Corporation's stock (NYSE:DHR) fell by 0.3% despite a recent upgrade from Bank of America from neutral to buy, along with various adjustments in price targets from other analysts, likely reflecting market fluctuations rather than any negative news about the company's earnings or outlook.
	2024-12-03	-0.17 %
Danaher Corporation (DHR) experienced a slight decline of 0.17% in stock price, attributed to a decrease in shares held by Bridgewater Associates LP and mixed investment activity from other institutional investors despite positive earnings and analyst ratings.
	2024-11-25	+0.78 %
Danaher Corporation (DHR) stock rose by 0.78% likely due to strong quarterly earnings that exceeded analyst expectations, along with considerable interest from institutional investors, which reflects confidence in the company's growth prospects.
	2024-11-21	+0.84 %
Danaher Corporation's stock (NYSE:DHR) increased by 0.84% due to positive earnings results that surpassed estimates and favorable analyst target price adjustments, despite a recent downgrade by StockNews from a buy to a hold rating.
	2024-11-04	-0.23 %
Danaher Corporation's stock (DHR) was down 0.23% despite an upgrade to an "outperform" rating from Wolfe Research, as analysts expressed mixed sentiment with adjustments to price targets, indicating potential volatility or profit-taking among investors following its recent earnings report.
	2024-10-30	-0.15 %
Danaher Corporation (DHR) stock declined by 0.15% after Assenagon Asset Management S.A. reduced its holdings by 26.9% in the third quarter, indicating potential bearish sentiment among institutional investors, despite recent positive earnings results and a generally favorable analyst outlook.
	2024-10-29	-0.59 %
Danaher Corporation's (DHR) stock fell by 0.59% after several large investors made adjustments to their holdings, including insider sales that may have raised concerns among investors.
	2024-10-22	-3.97 %
Danaher Corporation's stock (DHR) fell by 3.97% due to a broader market decline, where major indices like Sensex and Nifty experienced significant drops, contributing to negative market sentiment. Danaher Corporation's stock (DHR) experienced a decline of 3.97%, largely due to a combination of insider sales and mixed investor sentiment despite positive earnings performance, as analysts have set varying price targets and ratings for the stock. Danaher Corporation's stock (NYSE:DHR) fell by 3.97% amid insider selling and mixed analyst ratings, with significant sales by executives raising concerns among investors.
	2024-10-18	+0.88 %
Danaher Corporation's stock rose by 0.88% following institutional investors, particularly Wedge Capital Management, increasing their stakes, alongside positive analyst ratings and earnings performance exceeding expectations. The stock's increase may be attributed to enhanced investor confidence and optimism regarding future financial performance after the company's strong earnings report and overall institutional support.
	2024-10-14	+0.46 %
Danaher Corporation (NYSE:DHR) stock rose by 0.46% due to positive analyst upgrades and increased interest from institutional investors, reflecting strong earnings performance and overall confidence in the company's market position.
	2024-10-09	+0.16 %
Danaher Corporation's (DHR) stock rose by 0.16% following positive analyst upgrades and target price increases, indicating strong investor confidence despite a reduction in stake by one hedge fund. Danaher Corporation's stock (DHR) rose by 0.16% following a boost in institutional investments, including a 9.2% increase in holdings by Mather Group LLC and significant additions from other hedge funds, highlighting positive investor sentiment and confidence in the company's financial performance, including exceeding earnings expectations in the last quarter. Danaher Corporation's (DHR) stock rose by 0.16% following an increase in institutional holdings, positive quarterly earnings that exceeded analyst expectations, and favorable analyst ratings that indicate strong market confidence. Danaher Corporation (NYSE:DHR) saw a 0.16% increase in its stock price, driven by recent institutional investors like City Holding Co. and Vanguard Group boosting their holdings, reflecting positive market sentiment and confidence in the company's performance and growth potential.